RNAi mechanisms and applications

被引:184
作者
Kim, Daniel H. [1 ]
Rossi, John J. [1 ]
机构
[1] City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Biol, Duarte, CA 91010 USA
基金
美国国家卫生研究院;
关键词
D O I
10.2144/000112792
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Within the past two decades we have become increasingly aware of the roles that RNAs play in regulation of gene expression. The RNA world vas given a booster shot with the discovery of RNA interference (RNAi), a compendium of mechanisms involving small RNAs (less than 30 bases long) that regulate the expression of genes in a variety of eukaryotic organisms. Rapid progress in our understanding of RNAi-based mechanisms hits led to applications of this powerful process in studies of gene function as well as in therapeutic applications for the treatment of disease. RNAi-based therapies involve two-dimensional drug designs using only identification of good Watson-Crick base pairing between the RNAi guide strand and the tat-get, thereby resulting in rapid design and testing of RNAi triggers. To date there are several clinical trials using RNAi, and we should expect the list of ne v applications to grow, tit it phenomenal rate. This article summarizes our current knowledge about the mechanisms and applications of RNAi.
引用
收藏
页码:613 / 616
页数:4
相关论文
共 34 条
[11]   Unlocking the potential of the human genome with RNA interference [J].
Hannon, GJ ;
Rossi, JJ .
NATURE, 2004, 431 (7006) :371-378
[12]   Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma [J].
Hu-Lieskovan, S ;
Heidel, JD ;
Bartlett, DW ;
Davis, ME ;
Triche, TJ .
CANCER RESEARCH, 2005, 65 (19) :8984-8992
[13]  
Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8
[14]   Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy [J].
Kim, DH ;
Behlke, MA ;
Rose, SD ;
Chang, MS ;
Choi, S ;
Rossi, JJ .
NATURE BIOTECHNOLOGY, 2005, 23 (02) :222-226
[15]   Transvascular delivery of small interfering RNA to the central nervous system [J].
Kumar, Priti ;
Wu, Haoquan ;
McBride, Jodi L. ;
Jung, Kyeong-Eun ;
Kim, Moon Hee ;
Davidson, Beverly L. ;
Lee, Sang Kyung ;
Shankar, Premlata ;
Manjunath, N. .
NATURE, 2007, 448 (7149) :39-43
[16]   The nuclear RNase III Drosha initiates microRNA processing [J].
Lee, Y ;
Ahn, C ;
Han, JJ ;
Choi, H ;
Kim, J ;
Yim, J ;
Lee, J ;
Provost, P ;
Rådmark, O ;
Kim, S ;
Kim, VN .
NATURE, 2003, 425 (6956) :415-419
[17]   The role of PACT in the RNA silencing pathway [J].
Lee, Y ;
Hur, I ;
Park, SY ;
Kim, YK ;
Suh, MR ;
Kim, VN .
EMBO JOURNAL, 2006, 25 (03) :522-532
[18]   Antiviral RNAi therapy: emerging approaches for hitting a moving target [J].
Leonard, JN ;
Schaffer, DV .
GENE THERAPY, 2006, 13 (06) :532-540
[19]   Cleavage of the siRNA passenger strand during RISC assembly in human cells [J].
Leuschner, PJF ;
Ameres, SL ;
Kueng, S ;
Martinez, J .
EMBO REPORTS, 2006, 7 (03) :314-320
[20]   Argonaute2 is the catalytic engine of mammalian RNAi [J].
Liu, JD ;
Carmell, MA ;
Rivas, FV ;
Marsden, CG ;
Thomson, JM ;
Song, JJ ;
Hammond, SM ;
Joshua-Tor, L ;
Hannon, GJ .
SCIENCE, 2004, 305 (5689) :1437-1441